Open Access Open Access  Restricted Access Subscription or Fee Access

Primary Dysmenorrhea: A Review with Special Reference to Unani Concepts

Hina Rehman, Wajeeha Begum, Humyra Tabasum, Farzana Anjum

Abstract


Dysmenorrhea is potentially the most common and most underdiagnosed gynecologic condition. It is characterized by crampy lower abdominal pain radiating to back and thigh. Nausea, vomiting, headache and diarrhea are frequent accompanying symptoms. An excess or imbalance of prostaglandins, vasopressin, and chemical substances derived from phospholipids play an important role in generating primary dysmenorrhea symptoms, although exact pathology is still difficult to understand. An estimated 10–30% of all working or studying women lose 1–3 working days per month due to dysmenorrhea. Despite the high prevalence, most of the girls are under-treated because of common societal beliefs regarding a lack of effective treatment and expectations about the burden of menstruation. Although conventional medicines are the initial first line therapy, some women may not always find them effective or acceptable due to intolerance or contraindications. A number of alternative and complementary therapies are available; Unani system of medicine is one of them. The condition is clearly described by various legendary Unani physicians as Darde Rehm centuries earlier. The focus of this review article is on Unani concept and modern aspect of primary dysmenorrhea

Keywords


Primary dysmenorrhea, Unani system, prostaglandins, Darde Rehm

Full Text:

PDF

References


Singh A, et al. Prevalence and severity of dysmenorrhea: a problem related to menstruation, among first and second year female medical students. Indian J Physiol Pharmacol. 2008; 52(4): 389–97p.

Dawood YM. Dysmenorrhea. Glob. libr. Women’s Med. June 2008.

Harel Z. Dysmenorrhea in adolescents and young adults: an update on pharmacological treatments and management strategies Review. Expert Opin. Pharmacother. 2012; 13(15): 2157–70p.

Montoya JS, et al. Menstrual disorders in adolescents, Bol Med Hosp Infant Mex. 2012; 69(1): 60–72p.

Mayo LJ. A Healthy Menstrual Cycle. Clinical Nutrition Insights. 1997. 5(9). 1-8p.

Gauga T, et al. Primary dysmenorrhea leading problem of adolescent gynecology (Review). Georgian Medical News. 2012; 207(6): 7–13p.

Harel Z. Dysmenorrhea in adolescents and young adults: etiology and management. J Pediatr Adolesc Gynecol. 2006; 19: 363–71p.

Fujiwara T, et al. Adverse effects of dietary habits on menstrual disorders in young women. The Open Food Science Journal. 2007; 1: 24–30p.

Lakshmi A, et al. Prevalence of premenstrual syndrome and dysmenorrhea among female medical students and its association with college absenteeism. Int J Biol Med Res. 2011; 2(4):1011–6p.

Smith R, et al. NSAIDs: Is newer better for dysmenorrhea? The Journal of Family Practice. 2002 July; 4(7): 4p.

Dysmenorrhea: The Neglected Syndrome. Access date: 2012/3/25. Available from: http://wholehealthmedia.com/Dysmenorrhea%20PDF.pdf.

Copeland LJ, Jarrell JF, McGregor JA. Textbook of Gynaecology. Philadelphia: WB Saunders Company; 1993; 398–403p.

O’ Dowd MJ, Philipp EE. The History of Obstetrics and Gynaecology. New York: The Parthenon Publishing Group; 2003; 17, 43, 47, 51, 262, 345–47p.

Sadek AA. History of Medicine – Some aspects of medicine in pharonic Egypt. Australian Academy of Medicine and Surgery. 2001.

Fred M. Howard, Paul Perry, James Carter, et al. Pelvic Pain: Diagnosis and Management. Philadelphia: Lippincot William & Wilkins; 2000; 100p.

Razi ABZ. Al Hawi Fil Tib. Vol IX. New Delhi: CCRUM; 2001; 151–68p.

Ibn Sina. Al Qanoon Fil Tib (Urdu trans. by Kantoori GH). New Delhi: Ejaz Publication House; 2010; 447–8p.

Ortiz MI. Primary dysmenorrhea among Mexican university students: prevalence, impact and treatment. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2010; 152: 73–7p.

Morrow C, Naumburg EH. Dysmenorrhea. Access on 12013/4/5. Available from: pdf.edocr.com/26d094db527882e8df3e401eaa6d52e87a7f9352

Aggarwal AK, Aggarwal A. A Study of dysmenorrhea during menstruation in adolescent girls. Indian J Community Med. 2010 January; 35 (1): 159–64p.

Borgelt LM, O’Connell MB, Smith JA. women’s health across the lifespan: a pharmacotherapeutic approach. American Society of Health-System Pharmacist. 2010. Acess on 2012/2/11. Available from: Amazon.com.

Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhea in young women. Br J Obstet Gynaecol. 1990; 97(7): 588–94p.

Zahradnik HP, Hanjalic-Beck A, Groth K. Non-steroidal anti-inflammatory drugs and hormonal contraceptives for pain relief from dysmenorrhea: a review. Contraception. 2010 Mar; 81(3): 185–96p.

Wills H, Demetriou C, May K, et al. NHS Evidence – Women’s Health, Dysmenorrhea. Annual Evidence Update March 2010. Nuffield Department of Obstetrics and Gynaecology, University of Oxford. Access on 2012/10/26.

arms.evidence.nhs.uk/resources/hub/35914/attachment.

Lefebvre G, Pinsonneault O. Primary Dysmenorrhea Consensus Guidelines. JOGC December 2005. 169; 117–1130p.

Rigi SN, Kermansaravi F, Navidian A, et al. Comparing the analgesic effect of heat patch containing iron chip and ibuprofen for primary dysmenorrhea: a randomized controlled trial. BMC Women’s Health. 2012; 12: 25p.

Dawood YM. Primary dysmenorrhea advances in pathogenesis and management. Obstet Gynecol. 2006 August; 108(2): 428–41p.

Wang L, Wang X, Wang W, eet al. Stress and dysmenorrhea: a population based prospective study. Occup Environ Med. 2004; 61: 1021–6p.

Khan A. Haziq, 1st Edn. Karachi: Madina Publishing Company. 1983; 467–71p.

Fortier MA, Krishnaswamy K, Danyod G, et al. A postgenomic integrated view of prostaglandins in reproduction: implication for other body system. J Physiol Pharmacol. 2008; 59(1): 65–89p.

Abu JI, Konje JC. Leokotrienes in Gynecology: the hypothetical value of anti-leukotrienes therapy in dysmenorrhea and endometriosis. Human Reproduction Update. 2000; 6(2): 200–5p.

Ricciotti E, Gareet A, Gerald F. Prostaglandins and Inflammation. Arterioscler Thromb Vasc Biol. 2011 May; 31(5): 986–1000p.

Parente L, Perretti M. Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight. Biochem Pharmacol. 2003; 65: 153–9p.

Khan A. Al Akseer (Urdu trans. by Kabeeruddin) Vol II. New Delhi: Ejaz Publishing House; 2003: 1356–64p.

Arzani A. Tibbe Akbar. Deoband: Faisal Publication. YNM. 617p.

Majoosi ABA. Kamilus Sanaa (Urdu trans. by Kantoori GH) Vol I & II. New Delhi: Idarae Kitabul Shifa; 2010. Vol I 533–34. Vol II–128p.

Ibn Rushd. Kitabul Kulliyat, 2nd Edn. New Delhi. CCRUM. 1987; 56, 114, 116, 226, 299p.

Azam MK. Ramooze Azam. (Persian) Vol II. New Delhi. CCRUM. 2006. 247p.

Jurjani I. Zakheerae Khawarzam Shahi (Urdu trans. by Khan AH). Vol II, III, VI. Lucknow: Munshi Nawal Kishore; 2010. Vol II 48, Vol III 40, Vol VI; 590, 598, 635p.

[CCRUM] Central Council Research of Unani Medicine. Kitabul Moalija Amraze Umoomi Dar Tibbe Unani. New Delhi: CCRUM. 2004; 169–70p.

Ahmad J. Tazkarae Jaleel. New Delhi: CCRUM. 2008; 353–4p.

Proctor M, Murphy PA. Herbal and dietary therapies for primary and secondary dysmenorrhea. Cochrane Database Systemic Review. 2009; 2: CD002124.

Ziaei S, Zakeri M, Kazemnejad A. A randomised controlled trial of vitamin E in the treatment of primary dysmenorrhea. BJOG. 2005 April; 112: 466–9p.

Lysakowski C, Dumont L, Czarnetzki C, et al. Magnesium as an adjuvant to postoperative analgesia: a systematic review of randomized trials. A & A. 2007 June; 104(6): 1532–9p.

Zafari M, Tofighi M, Aghamohammady A, et al. Comparison of the effect of acupressure, fish oil capsules and ibuprofen on treatment of primary dysmenorrhea. Afr J Pharm Pharmaco. 2011 August; 5(8). 1115–9p.

Ou M, Hsu TF, Lai AC, et al. Pain relief assessment by aromatic essential oil massage on outpatients with primary dysmenorrhea: A randomized, double-blind clinical trial. J Obstet. Gynaecol. Res. 2012 May; 38(5): 817–22p.

Brown J, Brown S. Exercise for dysmenorrhea Cochrane Db Syst Rev. 2010; 2: CD004142.

Smith CA, Zhu X, He L, et al. Acupuncture for primary dysmenorrhea. Cochrane Db Syst Rev. 2011; 1: CD007854.

Proctor M, Farquhar C, Stones W, et al. Transcutaneous electrical nerve stimulation for primary dysmenorrhea. Cochrane Db Syst Rev. 2010; 1. CD002123.

Zhu X, Proctor M, Bensoussan A, et al. Chinese herbal medicine for primary dysmenorrhea. Cochrane Db Syst Rev. 2008; 2: CD005288.

Proctor ML, Hing W, Johnson TC, et al. Spinal manipulation for primary and secondary dysmenorrhea. Cochrane Db Syst Rev. 2001; 4: CD002119.

Proctor M, Murphy PA, Pattison HM, et al. Behavioural interventions for dysmenorrhea. Cochrane Db Syst Rev. 2007; 3: CD002248.

Marjoribanks J, Proctor M, Farquhar C, et al. Nonsteroidal anti-inflammatory drugs for dysmenorrhea. Cochrane Db Syst Rev. 2010; 1: CD001751.

Harel Z, Biro FM, Kottenhahn RK, et al. Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents. Am J Obstet Gynecol. April 1996; 174(4): 1335–8p.

Latthe PM, Proctor ML, Farquhar CM, et al. Surgical interruption of pelvic nerve pathways in dysmenorrhea: a systematic review of effectiveness. Acta Obstet Gynecol Scand. 2007; 86(1): 4–15p




DOI: https://doi.org/10.37591/rrjoush.v1i1.3567

Refbacks

  • There are currently no refbacks.